Rahmathullah S.N.: Key Takeaways on Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders
Rahmathullah S.N., Clinical Pharmacist at IQRAA International Hospital and Research Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Indian Journal of Hematology and Blood Transfusion, adding:
”Delighted to share our latest publication in the Indian Journal of Hematology and Blood Transfusion (Springer) titled ‘Achieving Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders: Experience from a Resource-Limited Setting.’
This work details a retrospective study of surgical procedures in patients with congenital bleeding disorders, such as Hemophilia, at a tertiary care center in South India.
Key takeaways include:
- Individualized perioperative planning enables patients with Hemophilia and other clotting factor deficiencies to safely undergo invasive surgeries.
- In Hemophilia A, Emicizumab prophylaxis significantly reduced the requirements for factor VIII and bypassing agents during surgery.
- Success in resource-limited settings depends on multidisciplinary coordination and pragmatic resource utilization.
I am deeply grateful to my mentor, senior hemato-oncologist Dr. Raghuveer Prabhu, whose guidance was crucial to this study, and to Dr. Javed Ahammad, for his dedicated expertise.
Thanks also to my co-author Dr. Henna Pokka and the entire clinical team at IQRAA International Hospital and Research Centre for their commitment to patient care.
We hope this work adds to the evidence base from India and supports clinicians facing similar challenges in resource-constrained environments globally.”
Title: Achieving Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders: Experience from a Resource-Limited Setting
Authors: Henna Pokka, Raghuveer S. Prabhu, S. N. Rahmathullah, Javed Ahammad

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients